Efficacy of Weikang Pian in Patients with Functional Dyspepsia: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial

Table 3

Baseline of characteristics.

Parameters	Placebo	Group 1	Group 2	Group 3
Gender (male/female)	7/8	8/7	6/9	5/10
Age (year)	40.40 ± 8.09	38.67 ± 9.29	39.07 ± 7.85	38.60 ± 9.34
Weight (kg)	60.73 ± 6.80	60.99 ± 7.49	59.29 ± 6.20	59.68 ± 6.71
Height (cm)	165.07 ± 4.85	165.33 ± 6.99	162.20 ± 5.82	163.87 ± 6.08
Smoking (yes/no)	4/11	4/11	3/12	2/13
Postprandial distension	2.53 ± 0.64	2.13 ± 0.83	2.20 ± 0.68	2.80 ± 0.41
Early satiety	2.00 ± 0.65	1.53 ± 0.52	1.93 ± 0.59	1.87 ± 0.52
Epigastric burning	1.33 ± 0.72	1.47 ± 0.83	1.33 ± 0.72	1.33 ± 0.49
Epigastric pain	4.49 ± 1.21	4.25 ± 1.28	4.33 ± 1.08	4.47 ± 0.69
GER (%)	42.62 ± 19.47	35.01 ± 18.57	31.41 ± 13.08	27.41 ± 14.01
GET/2 (h)	2.89 ± 1.39	3.70 ± 2.04	3.85 ± 1.92	4.63 ± 2.36

Group 1-2 tablets of WKP, 600 mg flavonoids; Group 2-3 tablets of WKP, 900 mg flavonoids; Group 3-3 tablets of WKP, 1200 mg flavonoids.